Status:
COMPLETED
Real-world Clinical Benefit Evaluation in Breast Cancer Patients With Pharmaceutical Interventions for Cancer-related Fatigue
Lead Sponsor:
National Defense Medical Center, Taiwan
Collaborating Sponsors:
Taichung Veterans General Hospital
E-Da Cancer Hospital
Conditions:
Cancer-related Fatigue
Eligibility:
All Genders
Brief Summary
This retrospective study is to collect and analyze the data from medical records within the period that breast cancer patient is receiving NHI-covered CRF treatment. This study will evaluate the clini...
Detailed Description
This is a single arm, multicenter, and retrospective study. About 200 breast cancer patients' data from medical records are expected to collect and analyze in this retrospective study. The data collec...
Eligibility Criteria
Inclusion
- breast cancer patients who approved to use NHI to pay for cancer-related fatigue treatment drug
Exclusion
- N/A
Key Trial Info
Start Date :
September 8 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
261 Patients enrolled
Trial Details
Trial ID
NCT05428527
Start Date
September 8 2021
End Date
December 31 2023
Last Update
July 3 2024
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
E-Da Cancer Hospital
Kaohsiung City, Taiwan
2
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
3
Chang Gung Memorial Hospital, Keelung
Keelung, Taiwan
4
China Medical University Hospital
Taichung, Taiwan